Data Safety Monitoring Board (DSMB) recommendation to initiate second cohort follows review of Phase 1/Phase 2 LION-CS101 ...

Find insight on Gilead Sciences, Sarepta Therapeutics and more in the latest Market Talks covering the health care sector.

Spring, summer and fall bulbs do benefit from fertilization! The soil fertility and pH in your garden plays a role in ...

2021;6(11):887-896. [2] AskBio Announces First Patient Dosed in Phase 1 / Phase 2 Trial of AB-1003 Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). Available at ...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the advancement of the Phase 1/Phase 2 LION-CS101 clinical trial of ...

today announced the advancement of the Phase 1/Phase 2 LION-CS101 clinical trial of investigational gene therapy AB-1003 in patients with limb-girdle muscular dystrophy type 2I/R9 (LGMD2I/R9 ...

Mizuho views the selloff in shares of Sarepta (SRPT) yesterday due to concerns about Elevidys adoption as a result of the fatal acute liver ...

With that, the timing of Prada’s bullet bra makes sense. While the name sounds violent (another descriptor for the design is ...

Columnist Patrick Moeschen offers a retrospective of what he did and didn't know about living with muscular dystrophy over ...

Competing interests SB and SD deliver privately hosted educational courses on Pregnancy-Related Pelvic Girdle Pain. Provenance and peer review Not commissioned; externally peer reviewed. Supplemental ...